FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry and medicine, namely to an agent for tumour therapy, active against tumours of mice: lymphatic leukaemia P-388, Ehrlich tumours, Lewis lung epidermoid carcinoma, V-16 melanoma, cervical cancer cervix RShM-5, AKATOL intestinal cancer and adenocarcinoma Ca 755. Proposed agent contains (wt. %): 1.2 % n-{12-(β-d-xylopyranosyl)-5,7-dioxo-indolo[2,3-a]pyrrolo[3,4-c]carbazol-6-yl}pyridine-2-carboxamide; 13.0 % dimethylsulphoxide (DMSO); 47.4 % of Solidone 17PF, 38.4 % of ethyl alcohol (95 %).
EFFECT: invention provides creating a new anticancer agent of precise dosing characterized by high cytostatic effect, good solubility and stability during storage.
1 cl, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
| ANTI-CANCER DRUG TOPOISOMERASE I INHIBITOR | 2022 |
|
RU2786727C1 |
| N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
| METHOD FOR PRODUCING AMINO ACID ANALOGUES OF THE ANTITUMOUR ANTIBIOTIC REBECCAMYCIN | 2020 |
|
RU2755572C1 |
| METHOD OF PRODUCING INDOLO[2,3]PYRROLO[3,4-c]CARBAZOLE-5,7-DIONES N-GLYCOSIDES EXHIBITING CYTOTOXIC AND ANTICANCER ACTIVITY | 2009 |
|
RU2427585C9 |
| INDOLOCARBAZOLE DERIVATIVE BLOCKING TUMOUR VASCULOGENIC MIMICRY | 2014 |
|
RU2557554C1 |
| ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
| METHOD FOR TREATMENT OF SW620 HUMAN COLON CANCER IN EXPERIMENT | 2017 |
|
RU2665168C1 |
| DERIVATIVES OF GLYCOSIDES OF INDOLO[2,3-A]-PYRROLO[3,4-C]CARBAZOL-5,7-DIONES ELICITING CYTOTOXIC AND ANTITUMOR ACTIVITY | 2003 |
|
RU2255089C1 |
| AGENT FOR TREATING HORMONE-DEPENDENT TUMORS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2703533C1 |
